Cognitive Group for Cognition

Phase-Based Progress Estimates
View Heights Convalescent Hospital, Los Angeles, CA
Cognition+2 More
Cognitive Training - Behavioral
All Sexes
What conditions do you have?

Study Summary

The purpose of the study is to evaluate the feasibility of implementing cognitive training with 40 patients living with schizophrenia and schizoaffective disorder. The study aims to explore if cognitive training as an intervention can improve cognition, symptomology, social cognition, and psychosocial function which has been determined through literature to be impacted within this population. The results of this study will help shed light on utilizing additional resources to aid in decreasing relapse and continued hospitalizations.

Eligible Conditions

  • Cognition
  • Schizoaffective
  • Schizophrenia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 15-20 minutes

10-15 minutes
Montreal Cognitive Assessment (MoCA)
Multidimensional Schizotypy Scale - Brief Version (MSS-B)
15-20 minutes
Davos Assessment of Cognitive Biases Scale (DACOBS)
5-15 minutes
Illness Management and Recovery Scale - Consumer Self-Rating, IMRS

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Cognitive Group
1 of 1
Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Cognitive Group · No Placebo Group · N/A

Cognitive Group
Experimental Group · 1 Intervention: Cognitive Training · Intervention Types: Behavioral
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Training
Completed Phase 3

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 15-20 minutes

Trial Background

Andre Pierre Longino M.A., Researcher
Principal Investigator
Alliant International University
Closest Location: View Heights Convalescent Hospital · Los Angeles, CA
Photo of Los Angeles  1Photo of Los Angeles  2Photo of Los Angeles  3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Cognition
0 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are of any ethnicity.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.